AAPG Financials
Ascentage Pharma Group International - Financial statements & key metrics
Stock Price
$23.95
Market Cap
$2.24B
EPS
$-2.05
Income Statement Highlights
Most Recent Quarter: 2025-12-31
Revenue
$558.48M
Gross Profit
$426.75M
Operating Income
$-1.18B
Net Income
$-1.21B
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$3.97B
Total Liabilities
$2.63B
Shareholders Equity
$1.33B
Cash & Equivalents
$2.47B
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-111.36M
CapEx
$24.29M
Free Cash Flow
$-135.65M
Profitability Metrics
Gross Margin
91.5%
Operating Margin
-1.9%
Net Margin
-2.2%
ROE
-1.5%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is AAPG revenue?
AAPG's most recent quarterly revenue was $558.48M. Annual revenue can be calculated by summing the four most recent quarters.
Is AAPG profitable?
AAPG reported a loss of $1.21B in the most recent quarter. The net profit margin is -2.2%.
What is AAPG market cap?
AAPG has a market capitalization of $2.24B, making it a mid-cap stock.
Does AAPG have debt?
View AAPG's balance sheet for debt information.
What is AAPG cash flow?
AAPG's most recent quarterly free cash flow was $-135.65M.